Cytek BioSciences Inc

NASDAQ:CTKB   3:59:52 PM EDT
9.77
-0.29 (-2.88%)
Other Pre-Announcement

Cytek Biosciences Reports First Quarter 2022 Financial Results

Published: 05/11/2022 20:58 GMT
Cytek BioSciences Inc (CTKB) - Cytek Biosciences Reports First Quarter 2022 Financial Results.
Sees FY Revenue $160 Million to $168 Million.
Q1 Revenue Rose 44 Percent to $35.1 Million.
Says Now Expects Full Year 2022 Revenue to Be Closer to High End of Range of $160 Million to $168 Million.
Qtrly Loss per Share $0.02.